Video Experimental Relacionado
Updated: Aug 14, 2026
08:24
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Manejo de la insuficiencia cardíaca. I. Tratamiento farmacológico de tratamiento farmacológico
D W Baker1, M A Konstam, M Bottorff
1Health Sciences Program, RAND, Santa Monica, Calif.
JAMA
|November 2, 1994
Resumen
Los inhibidores de la enzima de conversión de la angiotensina (ECA) se recomiendan para todos los pacientes con insuficiencia cardíaca. Otros medicamentos como los diuréticos, la digoxina, el dinitrato de isosorbida y la hidralazina tienen funciones específicas basadas en los síntomas y la tolerancia del paciente.
Área de la Ciencia:
- Cardiología Cardiología.
- Farmacología Farmacología.
Sus antecedentes:
- La insuficiencia cardíaca debido a la disfunción sistólica ventricular izquierda es un desafío clínico significativo.
- El manejo farmacológico eficaz es crucial para mejorar los resultados de los pacientes.
Objetivo del estudio:
- Para resumir las recomendaciones del panel de expertos para el tratamiento farmacológico de la insuficiencia cardíaca.
- Proporcionar orientación para la toma de decisiones clínicas en el manejo de la insuficiencia cardíaca.
Principales métodos:
- Revisión sistemática de los estudios de la lengua inglesa desde 1966 hasta 1993.
- La inclusión de grandes ensayos prospectivos para la eficacia y estudios más pequeños para los efectos adversos.
- Análisis de ensayos clínicos aleatorizados basados en criterios de calidad predefinidos.
Principales resultados:
- Los inhibidores de la enzima de conversión de la angiotensina (ECA) son la terapia de primera línea para la insuficiencia cardíaca.
- Los diuréticos deben usarse con precaución para facilitar la titulación del inhibidor de la ECA.
- La digoxina está reservada para pacientes sintomáticos refractarios a los inhibidores de la ECA y los diuréticos.
Conclusiones:
- Los inhibidores de la ECA deben administrarse a todos los pacientes con insuficiencia cardíaca elegibles.
- El uso juicioso de diuréticos es esencial para una dosificación óptima del inhibidor de la ECA.
- Las terapias alternativas como el isosorbido dinitrato / hidralazina son opciones para la intolerancia al inhibidor de la ECA o los síntomas refractarios.
Videos de Conceptos Relacionados
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...